BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/13/2024 7:07:39 AM | Browse: 61 | Download: 196
 |
Received |
|
2024-05-14 16:28 |
|
Peer-Review Started |
|
2024-05-14 16:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-06-06 03:00 |
|
Revised |
|
2024-06-06 10:38 |
|
Second Decision |
|
2024-06-24 02:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-06-24 08:54 |
|
Articles in Press |
|
2024-06-24 08:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-06-30 21:04 |
|
Typeset the Manuscript |
|
2024-07-17 13:17 |
|
Publish the Manuscript Online |
|
2024-08-13 07:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https: //creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Hidden army within: Harnessing the microbiome to improve cancer treatment outcomes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ippokratis Messaritakis, Georgios Vougiouklakis, Asimina Koulouridi, Aris P Agouridis and Nikolaos Spernovasilis |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nikolaos Spernovasilis, BSc, MD, MSc, PhD, Director, Director, Department of Infectious Diseases, German Oncology Center, Nikis 1, Limassol 4108, Cyprus. nikspe@hotmail.com |
| Key Words |
Gut microbiome; Cancer treatment; Immunotherapy; Microbiome-based interventions; Dysbiosis; Precision oncology |
| Core Tip |
Understanding the intricate relationship between the gut microbiome and cancer treatment outcomes is pivotal in modern oncology. Dysbiosis, an imbalance in gut microbial communities, significantly influences tumor initiation, progression, and response to therapy. Harnessing the microbiome's potential offers novel avenues for personalized cancer care, including optimizing treatment strategies and enhancing immunotherapy efficacy. Multidisciplinary collaboration, standardized methodologies for microbiome profiling, and the development of microbial biomarkers are essential for translating microbiome research into clinical practice. Ethical considerations and regulatory oversight are paramount in ensuring equitable access to emerging microbiome-based interventions while promoting transparency and education among healthcare professionals and the public. |
| Publish Date |
2024-08-13 07:07 |
| Citation |
<p>Messaritakis I, Vougiouklakis G, Koulouridi A, Agouridis AP, Spernovasilis N. Hidden army within: Harnessing the microbiome to improve cancer treatment outcomes. <i>World J Clin Cases</i> 2024; 12(28): 6159-6164</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i28/6159.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i28.6159 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
